Pleo Stroph
FDA Label NDC 60681-9012

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Stroph (NDC 60681-9012). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, inactive ingredients, tamper evident, acute, chronic, warning, principal display panel - 80 tablet carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Each tablet contains 250 mg Strophanthus g. 4X.

Inactive Ingredients

lactose, potato starch, magnesium stearate.

Tamper Evident

Do not use this product if imprinted inner blister foil is broken.

Acute

1 tablet every half to full hour up to a max. of 12 times daily.

Chronic

2 tablets daily.

Warning

If symptoms persist more than a few days, contact a licensed practitioner right away. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.

Principal Display Panel - 80 Tablet Carton

Pleo™ Stroph
TABLETS 4X

Homeopathic
Preparation for a
Healthy Heart

80 TABLETS

Principal Display Panel (80 Tablet Carton)

Principal Display Panel (80 Tablet Carton)

* Please review the disclaimer below.